These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1505154)

  • 1. The relationship between alfentanil distribution kinetics and cardiac output.
    Henthorn TK; Krejcie TC; Avram MJ
    Clin Pharmacol Ther; 1992 Aug; 52(2):190-6. PubMed ID: 1505154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recirculatory and compartmental pharmacokinetic modeling of alfentanil in pigs: the influence of cardiac output.
    Kuipers JA; Boer F; Olofsen E; Olieman W; Vletter AA; Burm AG; Bovill JG
    Anesthesiology; 1999 Apr; 90(4):1146-57. PubMed ID: 10201688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-adrenergic blockade affects initial drug distribution due to decreased cardiac output and altered blood flow distribution.
    Avram MJ; Krejcie TC; Henthorn TK; Niemann CU
    J Pharmacol Exp Ther; 2004 Nov; 311(2):617-24. PubMed ID: 15197245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alfentanil clearance is independent of the polymorphic debrisoquin hydroxylase.
    Henthorn TK; Avram MJ; Krejcie TC
    Anesthesiology; 1989 Nov; 71(5):635-9. PubMed ID: 2817455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacokinetics and locomotor activity of alfentanil in the horse.
    Pascoe PJ; Black WD; Claxton JM; Sansom RE
    J Vet Pharmacol Ther; 1991 Sep; 14(3):317-25. PubMed ID: 1744940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of physiologic models to predict the influence of changes in body composition and blood flows on the pharmacokinetics of fentanyl and alfentanil in patients.
    Björkman S; Wada DR; Stanski DR
    Anesthesiology; 1998 Mar; 88(3):657-67. PubMed ID: 9523809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-point sampling for assessment of constitutive, induced, and inhibited cytochrome P450 3A activity with alfentanil or midazolam.
    Chaobal HN; Kharasch ED
    Clin Pharmacol Ther; 2005 Nov; 78(5):529-39. PubMed ID: 16321619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of alfentanil before and after cardiopulmonary bypass in pigs: Part II.
    den Hollander JM; Burm AG; Vletter AA; Bovill JG
    J Cardiothorac Vasc Anesth; 1992 Jun; 6(3):313-5. PubMed ID: 1610997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indocyanine green kinetics characterize blood volume and flow distribution and their alteration by propranolol.
    Niemann CU; Henthorn TK; Krejcie TC; Shanks CA; Enders-Klein C; Avram MJ
    Clin Pharmacol Ther; 2000 Apr; 67(4):342-50. PubMed ID: 10801242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alfentanil-induced miosis as a surrogate measure of alfentanil pharmacokinetics in patients with mild and moderate liver cirrhosis.
    Baririan N; Van Obbergh L; Desager JP; Verbeeck RK; Wallemacq P; Starkel P; Horsmans Y
    Clin Pharmacokinet; 2007; 46(3):261-70. PubMed ID: 17328584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of parallel Erlang density functions to analyze first-pass pulmonary uptake of multiple indicators in dogs.
    Krejcie TC; Jacquez JA; Avram MJ; Niemann CU; Shanks CA; Henthorn TK
    J Pharmacokinet Biopharm; 1996 Dec; 24(6):569-88. PubMed ID: 9300351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of alfentanil administered at a variable rate during three types of surgery.
    Burm AG; Ausems ME; Spierdijk J; Stanski DR
    Eur J Anaesthesiol; 1993 Jul; 10(4):241-51. PubMed ID: 8330593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of alfentanil in man.
    Camu F; Gepts E; Rucquoi M; Heykants J
    Anesth Analg; 1982 Aug; 61(8):657-61. PubMed ID: 6124179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimal compartmental model of circulatory mixing of indocyanine green.
    Henthorn TK; Avram MJ; Krejcie TC; Shanks CA; Asada A; Kaczynski DA
    Am J Physiol; 1992 Mar; 262(3 Pt 2):H903-10. PubMed ID: 1558199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of duration of infusion on elimination rate of alfentanil].
    Castor G; Altmayer P; Venitz J
    Anaesthesiol Reanim; 1995; 20(4):97-100. PubMed ID: 7575958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition of alfentanil in burns patients.
    Macfie AG; Magides AD; Reilly CS
    Br J Anaesth; 1992 Nov; 69(5):447-50. PubMed ID: 1467073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The disposition of alfentanil in neonates with respiratory distress.
    Wiest DB; Ohning BL; Garner SS
    Pharmacotherapy; 1991; 11(4):308-11. PubMed ID: 1923912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of long-term drugs on alfentanil clearance in patients undergoing renal transplantation.
    Koehntop DE; Noormohamed SE; Fletcher CV
    Pharmacotherapy; 1994; 14(5):592-9. PubMed ID: 7997393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alfentanil pharmacokinetics in preterm infants.
    Marlow N; Weindling AM; Van Peer A; Heykants J
    Arch Dis Child; 1990 Apr; 65(4 Spec No):349-51. PubMed ID: 2337359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of cardiac output without right heart catheterization: reliability, advantages, and limitations of a left-sided indicator dilution technique.
    van den Berg E; Pacifico A; Lange RA; Wheelan KR; Winniford MD; Hillis LD
    Cathet Cardiovasc Diagn; 1986; 12(3):205-8. PubMed ID: 3524851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.